Medicine for treating pulmonary fibrosis

A technology of pulmonary fibrosis and drugs, applied in the field of drugs for the treatment of pulmonary fibrosis, can solve problems that are difficult to completely treat diseases with complex pathogenesis
CN106389596AActive Publication Date: 2017-02-15GUANGXI UNIV OF CHINESE MEDICINE
4 Cites 3 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
GUANGXI UNIV OF CHINESE MEDICINE
Publication Date
2017-02-15

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a medicine for treating pulmonary fibrosis. The medicine for treating the pulmonary fibrosis is characterized in that the medicine prescription consists of traditional Chinese medicine gecko, ficus hirta, mango leaves, prismatomeria tetrandra and panax notoginseng. In the prescription, the gecko and the ficus hirta serve as medicines for reinforcing deficiency and strengthening body resistance, the mango leaves serve as medicines for diminishing inflammation, relieving cough and reducing phlegm, and the prismatomeria tetrandra and the panax notoginseng serve as medicines for removing blood stasis and eliminating stagnation. The prescription realizes reasonable medicine use according to the traditional Chinese medicine thought about treatment based on syndrome differentiation so as to achieve the effect of treating both symptoms and root causes. Experimental research proves the effectiveness and the action mechanism of the prescription on the pulmonary fibrosis, and the prescription can be applied to novel traditional Chinese medicines for developing and treating the pulmonary fibrosis.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the technical field of pulmonary fibrosis treatment, in particular to a medicine for treating pulmonary fibrosis. Background technique

[0002] Pulmonary fibrosis (PF) is a type of disease in which diffuse exudation, infiltration and fibrosis of the pulmonary interstitium are the main lesions. Its main symptoms include dyspnea, shortness of breath, dry cough, and wheezing. die. At present, its pathogenesis is still unclear, and with the continuous deterioration of environmental pollution, the incidence rate is increasing year by year. At present, Western medicine mainly uses hormones and immunosuppressant drugs for the traditional treatment of pulmonary fibrosis, but the curative effect is not ideal and there are side effects. There is no disease name for pulmonary fibrosis in TCM literature. According to its symptoms, it can be classified as "pulmonary obstruction", "lung impotence", "cough", etc. Clinical and practice shows...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More